GROUP ONE TRADING LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is and the CUSIP is 874060905. A total of 4 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2024$265,270
+961.0%
20,500
+1038.9%
0.00%
Q1 2024$25,002
-99.4%
1,800
-99.4%
0.00%
-100.0%
Q4 2023$4,088,355
-7.8%
286,500
-0.1%
0.01%
-26.7%
Q3 2023$4,435,249
+158.3%
286,700
+162.3%
0.02%
+150.0%
Q2 2023$1,717,103
+563.7%
109,300
+596.2%
0.01%
+500.0%
Q1 2023$258,736
-73.9%
15,700
-75.3%
0.00%
-50.0%
Q4 2022$990,600
+92.7%
63,500
+60.4%
0.00%
+100.0%
Q3 2022$514,000
-6.4%
39,600
+1.3%
0.00%0.0%
Q2 2022$549,000
-87.7%
39,100
-87.5%
0.00%
-75.0%
Q1 2022$4,469,000
-53.3%
312,100
-55.5%
0.00%
-50.0%
Q4 2021$9,566,000
-1.1%
701,800
+18.8%
0.01%
-20.0%
Q3 2021$9,672,000
-27.6%
590,500
-25.6%
0.01%
-37.5%
Q2 2021$13,356,000
-46.1%
793,600
-41.6%
0.02%
-56.8%
Q1 2021$24,797,000
+426.0%
1,358,000
+424.3%
0.04%
+362.5%
Q4 2020$4,714,000
+249.4%
259,000
+242.6%
0.01%
+100.0%
Q3 2020$1,349,000
-13.8%
75,600
-13.4%
0.00%
-42.9%
Q2 2020$1,565,000
-35.6%
87,300
-45.5%
0.01%
-65.0%
Q1 2020$2,430,000
-54.6%
160,100
-41.0%
0.02%
-44.4%
Q4 2019$5,351,000
+270.3%
271,200
+222.9%
0.04%
+200.0%
Q3 2019$1,445,000
+39.7%
84,000
+43.8%
0.01%
+33.3%
Q2 2019$1,034,000
+52.5%
58,400
+75.4%
0.01%
+12.5%
Q1 2019$678,000
+63.8%
33,300
+35.4%
0.01%
+100.0%
Q4 2018$414,00024,6000.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2023
NameSharesValueWeighting ↓
JANE STREET GROUP, LLC 858,500$11,108,9900.00%
GROUP ONE TRADING LLC 20,500$265,2700.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SIMPLEX TRADING, LLC 2,600$330.00%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders